The Heilongjiang pharmaceutical producer at the centre of a fake-drug scandal made 2.05 million doses of five kinds of defective drugs, according to the provincial Food and Drug Administration.
Mainland media reported that the drugs, produced in 16 batches by the Qiqihar No 2 Pharmaceutical Co, were sold in eight provinces.
Regions where the drugs were sold were not specified, except Guangdong and Shanxi , which had been named earlier. Another 3 million doses of other drugs were seized from the factory.
The administration claimed that the only area to have fatalities was Guangdong.
At least 11 patients treated at Sun Yat-sen University's No 3 Affiliated Hospital in Guangzhou died after receiving injections of defective medicine produced by the company.
The local Food and Drug Administration fined the company 19 million yuan and revoked its licence.
Investigators found that the drug was fatal because it was made using an industrial chemical that causes acute kidney failure. The factory purchased it from an unlicensed dealer in Jiangsu .
Authorities detained at least five staff of the company and the chemical dealer, Wang Guiping .